SLC5A2

#	Item
21	April 1, 2013 PRESS RELEASE Mitsubishi Tanabe Pharma Corporation U.S. FDA Approves Canagliflozin (TA[removed]for the Treatment of Adult Patients with Type 2 Diabetes Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-04-01 21:51:25 Diabetes mellitus SLC5A2 Anti-diabetic medication Diabetes Health Medicine
22	July 4, 2014 Press release: Mitsubishi Tanabe Pharma Corporation Daiichi Sankyo Co., Ltd. Marketing and Manufacturing Approval in Japan Received for Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2014-07-04 01:18:30 SLC5A2 Sodium-glucose transport proteins Canagliflozin Diabetes mellitus Chemistry Chūō-ku Osaka Biology Health Daiichi Sankyo Glycosides Diabetes
23	ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Add to Reading List Source URL: www.ema.europa.eu Language: English - Date: 2013-09-16 09:02:56 Anti-diabetic drugs Organochlorides Thiazolidinediones Bristol-Myers Squibb Dapagliflozin Glycosides Hypoglycemia SLC5A2 Placebo Medicine Health Chemistry
24	PDF Document Add to Reading List Source URL: www.fkdb.net Language: German - Date: 2013-09-28 11:31:17 Dapagliflozin Glycosides Organochlorides Phlorizin SLC5A2 Organic chemistry Sodium-glucose transport proteins Metformin SLC5A1 Solute carrier family Chemistry Bristol-Myers Squibb